{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:04:19Z","timestamp":1776963859465,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":3811,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.exphem.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T11:12:14Z","timestamp":1319454734000},"page":"22-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth"],"prefix":"10.1016","volume":"40","author":[{"given":"Anurima","family":"Majumder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Magis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung O.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Baskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Kirabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhizhuang Joe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirpal S.","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy M.","family":"Keser\u0171","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Sayeski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2011.10.003_bib1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","article-title":"Jak2 is essential for signaling through a variety of cytokine receptors","volume":"93","author":"Parganas","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2011.10.003_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2011.10.003_bib3","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"Peeters","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/gcc.20235","article-title":"A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia","volume":"44","author":"Griesinger","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2011.10.003_bib5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"Lacronique","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exphem.2011.10.003_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2011.10.003_bib7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2011.10.003_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2011.10.003_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2011.10.003_bib10","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1074\/jbc.C500138200","article-title":"Identification of an acquired JAK2 mutation in polycythemia vera","volume":"280","author":"Zhao","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib11","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib12","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.0509714102","article-title":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation","volume":"102","author":"Lu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.10.003_bib13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib14","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib15","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2009-12-257063","article-title":"Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice","volume":"116","author":"Marty","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib16","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1182\/blood-2007-05-091579","article-title":"Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice","volume":"111","author":"Xing","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib17","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood-2009-04-215848","article-title":"Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease","volume":"115","author":"Akada","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib18","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood-2009-12-259747","article-title":"JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib19","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/jm049470k","article-title":"Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation","volume":"48","author":"Sandberg","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib20","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1158\/1535-7163.MCT-08-0279","article-title":"Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth","volume":"7","author":"Sayyah","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2011.10.003_bib21","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.bmcl.2009.04.138","article-title":"Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening","volume":"19","author":"Kiss","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.exphem.2011.10.003_bib22","doi-asserted-by":"crossref","first-page":"31399","DOI":"10.1074\/jbc.M110.168211","article-title":"Structure-function correlation of G6, a novel small molecule inhibitor of jak2: indispensability of the stilbenoid core","volume":"285","author":"Majumder","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib23","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1074\/jbc.M110.200774","article-title":"The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in\u00a0vitro and in\u00a0vivo","volume":"286","author":"Kirabo","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2404081","article-title":"JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders","volume":"20","author":"Quentmeier","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2011.10.003_bib25","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.1074\/jbc.M600064200","article-title":"Activated Jak2 with the V617F point mutation promotes G1\/S phase transition","volume":"281","author":"Walz","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1227\/01.NEU.0000109534.28063.5D","article-title":"The cell cycle: accelerators, brakes, and checkpoints","volume":"54","author":"Ivanchuk","year":"2004","journal-title":"Neurosurgery"},{"key":"10.1016\/j.exphem.2011.10.003_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0955-0674(03)00008-5","article-title":"Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells","volume":"15","author":"Stacey","year":"2003","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2011.10.003_bib28","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.10.003_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(95)01186-I","article-title":"Role of multiple cellular proteases in the execution of programmed cell death","volume":"375","author":"Kumar","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2011.10.003_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1073\/pnas.0308050100","article-title":"Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2011.10.003_bib31","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1038\/sj.onc.1208949","article-title":"Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1\/Bim complex","volume":"24","author":"Gomez-Bougie","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2011.10.003_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/excr.2000.4859","article-title":"Cleavage of Bax enhances its cell death function","volume":"256","author":"Wood","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2011.10.003_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1097-4644(20010101)80:1<53::AID-JCB60>3.0.CO;2-E","article-title":"N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death","volume":"80","author":"Gao","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.exphem.2011.10.003_bib34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1074\/jbc.274.2.1156","article-title":"Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1\/Fas death","volume":"274","author":"Gross","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib35","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib36","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1111\/j.1582-4934.2009.00661.x","article-title":"Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2\/STAT3\/STAT5 signalling","volume":"13","author":"Xiong","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.exphem.2011.10.003_bib37","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1371\/journal.pone.0000018","article-title":"Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F","volume":"1","author":"Zaleskas","year":"2006","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2011.10.003_bib38","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.V93.7.2369","article-title":"Constitutive activation of the JAK2\/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines","volume":"93","author":"Liu","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood.V86.5.1671.bloodjournal8651671","article-title":"Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3","volume":"86","author":"Wang","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2257.2006.00864.x","article-title":"The investigation of JAK2 mutation in Chinese myeloproliferative diseases-identification of a novel C616Y point mutation in a PV patient","volume":"29","author":"Zhang","year":"2007","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.exphem.2011.10.003_bib41","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.leu.2404325","article-title":"Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E","volume":"20","author":"Schnittger","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2011.10.003_bib42","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2011.10.003_bib43","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.exphem.2011.10.003_bib44","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","article-title":"MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients","volume":"108","author":"Pardanani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/379645a0","article-title":"Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor","volume":"379","author":"Meydan","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2011.10.003_bib46","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/excr.1998.4061","article-title":"Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase","volume":"241","author":"Kleinberger-Doron","year":"1998","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.exphem.2011.10.003_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/A:1017941625858","article-title":"Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes","volume":"223","author":"Gu","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.exphem.2011.10.003_bib48","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/blood-2009-03-209544","article-title":"Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells","volume":"115","author":"Will","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2011.10.003_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2407-11-24","article-title":"Bim and Mcl-1 exert key roles in regulating JAK2V617F cell survival","volume":"11","author":"Rubert","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.exphem.2011.10.003_bib50","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.2174\/092986710794182953","article-title":"The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors","volume":"17","author":"Baskin","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.exphem.2011.10.003_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1749-6632.1995.tb31392.x","article-title":"Raloxifene is a tissue-selective agonist\/antagonist that functions through the estrogen receptor","volume":"761","author":"Fuchs-Young","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.exphem.2011.10.003_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-3565(25)23086-5","article-title":"5-lipoxygenase inhibitory activity of zileuton","volume":"256","author":"Carter","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"suppl 1","key":"10.1016\/j.exphem.2011.10.003_bib53","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0020-7292(00)00351-9","article-title":"Sertaconazole: pharmacology of a gynecological antifungal agent","volume":"71","author":"Palacin","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.exphem.2011.10.003_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/cr020033s","article-title":"The combinatorial synthesis of bicyclic privileged structures or privileged substructures","volume":"103","author":"Horton","year":"2003","journal-title":"Chem Rev"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X11005005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:29:24Z","timestamp":1759566564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X11005005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0301472X11005005"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2011.10.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}